142-146 Hyperesensitivity

It is known that inhaled steroids can be used for the treatment of interstitial lung diseases such as sarcoidosis to avoid systemic side effects of oral or intravenous forms. However there is no information about the role of inhaled steroids in the treatment of hypersensitivity pneumonitis (HP). Here in, a 38 year-old male patient with chronic HP treated by 16 months of high dose inhaled steroid is presented. Inspite of avoiding antigen exposure as much as possible, persisting radiological abnormalities necessitated histopathological confirmation of the diagnosis even if early-good clinical response. All findings were resolved after therapy and no pathology has been detected in a 1.5 year of follow-up. The authors recommend that high dose inhaled steroids should be considered in the treatment of HP. This observation needs to be supported by studies in large series.